Important: New Login Process

We've updated our access and security system. The first time you log in, enter your work email, and we'll guide you through the process.

  • If your organization uses Single Sign-On (SSO), you will be redirected to your company's login portal.
  • If you log in with a username and password, you will be prompted to set a new password before accessing your account.

Go to the Login Page to get started.

We appreciate your cooperation during this transition. If you need assistance, please call +1 650-552-4224 or email support@biocentury.com.

BioCentury
ARTICLE | Company News

Merck KGaA, Palantir team up to drive cancer research data sharing and integration

November 20, 2018 11:35 PM UTC

Merck KGaA (Xetra:MRK) and big data company Palantir Technologies (Palo Alto, Calif.) plan to create a JV under the name Syntropy to help facilitate collaboration among cancer researchers.

Syntropy will offer a data integration software platform for users to gather, structure and analyze cancer data from disparate sources. The JV will also facilitate secure, traceable sharing of data between participating researchers and institutions...

Get Unlimited Access
Continue reading with a free trial.
Or Purchase This Article